N
Nektar Therapeutics
NKTR · NASDAQ · Healthcare · 2.1B
Closing price
$41.17
+0.91% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.7×
Enterprise value / EBITDAEV/EBITDA
-6.0×
Free cash flow yieldFCF yield
-30.0%
Return on equityROE
-182.6%
Operating margin
-236.8%
Net debt / EBITDAbalance-sheet strength
-1.0×
Interest coverage
-5.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.